SC 13G/A: ASPEN AEROGELS INC
Ticker: ASPN · Form: SC 13G/A · Filed: Oct 22, 2024 · CIK: 1145986
| Field | Detail |
|---|---|
| Company | Aspen Aerogels Inc (ASPN) |
| Form Type | SC 13G/A |
| Filed Date | Oct 22, 2024 |
| Risk Level | low |
| Pages | 5 |
| Reading Time | 6 min |
| Key Dollar Amounts | $0.00001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sc-13g-a
AI Summary
SC 13G/A filing by ASPEN AEROGELS INC.
Risk Assessment
Risk Level: low
FAQ
What type of filing is this?
This is a SC 13G/A filing submitted by Aspen Aerogels Inc (ticker: ASPN) to the SEC on Oct 22, 2024.
What is the risk level of this SC 13G/A filing?
This filing has been assessed as low risk.
What are the key financial figures in this filing?
Key dollar amounts include: $0.00001 (, Inc. (Name of issuer) Common Stock, $0.00001 par value (Title of class of securitie).
How long is this filing?
Aspen Aerogels Inc's SC 13G/A filing is 5 pages with approximately 1,562 words. Estimated reading time is 6 minutes.
Where can I view the full SC 13G/A filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 1,562 words · 6 min read · ~5 pages · Grade level 9.9 · Accepted 2024-10-22 19:40:02
Key Financial Figures
- $0.00001 — , Inc. (Name of issuer) Common Stock, $0.00001 par value (Title of class of securitie
Filing Documents
- ef20037565_sc13ga.htm (SC 13G/A) — 116KB
- ef20037565_ex99-1.htm (EX-99.1) — 7KB
- 0001140361-24-043939.txt ( ) — 125KB
(a)
Item 1 (a). Name of Issuer: Aspen Aerogels, Inc. This Schedule 13G/A is being filed solely to report that the reporting persons are no longer the beneficial owners of more than five percent of the class of securities due to changes in the outstanding number of securities.
(b)
Item 1 (b). Address of Issuer's Principal Executive Offices: 30 Forbes Road, Building B Northborough, MA 01532
(a)
Item 2 (a). Name of Person Filing: This schedule 13G with respect to the Common Stock is filed by the George Kaiser Family Foundation ("GKFF"), the sole member of Ventures, GKFF Ventures I, LLC ("Ventures"), and Mr. Kenneth J. Levit. The named individual is the officer of Ventures (the "Officer") and by virtue of such position may be deemed to have beneficial ownership of the Common Stock held by Ventures.
(b)
Item 2 (b). Address of Principal Business Office or, if none, Residence: The address of the principal business office of GKFF is 7030 South Yale Avenue, Suite 600, Tulsa, OK, 74136. The address of the principal business office of Ventures is 7030 South Yale Avenue, Suite 600, Tulsa, OK, 74136. The address of the principal business office of Mr. Levit is 7030 South Yale Avenue, Suite 600, Tulsa, OK, 74136.
(c)
Item 2 (c). Citizenship: GKFF was organized, associated or formed under the laws of the State of Oklahoma. Ventures was organized, associated, or formed under the laws of the State of Oklahoma. The Officer is a citizen of the United States of America.
(d)
Item 2 (d). Title of Class of Securities: Common Stock, par value $0.00001 per share
(e)
Item 2 (e). CUSIP No: 04523Y105 Item 3. If this Statement is filed pursuant to Rule 13d-1(b), or 13d-2(b), check whether the person filing is a: a. Broker or dealer registered under Section 15 of the Act; b. Bank as defined in Section 3(a)(6) of the Act; c. Insurance company as defined in Section 3(a)(19) of the Act; d. Investment company registered under Section 8 of the Investment Company Act of 1940; e. An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); f. An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); g. A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); h. A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); i. A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940; j. A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J); k. Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____ Item 4. The percentages used herein and in the rest of this Schedule 13G are calculated based upon a total of 77,082,075 shares of Common Stock issued and outstanding as of August 7, 2024, as reported in Aspen Aerogel, Inc.'s Form 10-Q for the quarter ending June 30, 2024. 3,167,322 shares of Aspen Aerogels, Inc. are held directly by Ventures and deemed beneficially owned by GKFF and the Officer. GKFF and the Officer disclaim beneficial ownership of the shares held directly by Ventures. A. GKFF (a) Amount Beneficially Owned: 3,167,322 shares (b) Percent of Class: 4.11% (c) Number of Shares as to which Such Person has: (i) sole power to vote or to direct the vote 3,167,322 shares (ii) shared power to vote or to direct the vote -0- shares (iii) sole power to d
SIGNATURES
SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: October 22, 2024 George Kaiser Family Foundation By: /s/ Kenneth J. Levit Kenneth J. Levit Executive Director GKFF Ventures I, LLC By: /s/ Kenneth J. Levit Kenneth J. Levit President By: /s/ Kenneth J. Levit Kenneth J. Levit, Individually EXHIBIT INDEX Exhibit A (99.1) - Joint Filing Agreement